Sofinnova Investments, Inc. Immatics N.V. Transaction History
Sofinnova Investments, Inc.
- $1.36 Billion
- Q1 2025
A detailed history of Sofinnova Investments, Inc. transactions in Immatics N.V. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 1,554,304 shares of IMTX stock, worth $9.61 Million. This represents 0.52% of its overall portfolio holdings.
Number of Shares
1,554,304
Previous 343,206
352.88%
Holding current value
$9.61 Million
Previous $2.44 Million
187.25%
% of portfolio
0.52%
Previous 0.2%
Shares
20 transactions
Others Institutions Holding IMTX
# of Institutions
83Shares Held
91MCall Options Held
201KPut Options Held
109K-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.7MShares$90.7 Million0.04% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$58 Million1.77% of portfolio
-
Suvretta Capital Management, LLC New York, NY9.14MShares$56.5 Million1.8% of portfolio
-
Wellington Management Group LLP Boston, MA8.58MShares$53 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY7.28MShares$45 Million0.39% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $471M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...